Extavia : EPAR - Public assessment report
Submitted by Anonymous (not verified) on 30 April 2025 - 1:00
Extavia : EPAR - Public assessment report
Human medicines European public assessment report (EPAR): Hyrimoz, adalimumab, Date of authorisation: 26/07/2018, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 29 April 2025 - 16:38
Human medicines European public assessment report (EPAR): Hyrimoz, adalimumab, Date of authorisation: 26/07/2018, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Alofisel, darvadstrocel, Date of authorisation: 23/03/2018, Revision: 12, Status: Withdrawn
Submitted by Anonymous (not verified) on 29 April 2025 - 16:30
Human medicines European public assessment report (EPAR): Alofisel, darvadstrocel, Date of authorisation: 23/03/2018, Revision: 12, Status: Withdrawn
CTIS newsflash - 29 April 2025
Submitted by Anonymous (not verified) on 29 April 2025 - 15:50
CTIS newsflash - 29 April 2025
List of eligible industry stakeholder organisations
Submitted by Anonymous (not verified) on 29 April 2025 - 15:00
List of eligible industry stakeholder organisations
Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 17, Status: Authorised
Submitted by Anonymous (not verified) on 29 April 2025 - 13:48
Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Zilbrysq, Zilucoplan, Date of authorisation: 01/12/2023, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 29 April 2025 - 13:11
Human medicines European public assessment report (EPAR): Zilbrysq, Zilucoplan, Date of authorisation: 01/12/2023, Revision: 2, Status: Authorised
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 18 March 2025, 09:30 (CET) to 18 March 2025, 13:00 (CET)
Submitted by Anonymous (not verified) on 29 April 2025 - 13:00
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 18 March 2025, 09:30 (CET) to 18 March 2025, 13:00 (CET)
EMA closed 1 May
Submitted by Anonymous (not verified) on 29 April 2025 - 12:00
EMA closed 1 May
Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation: 27/07/2020, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 29 April 2025 - 10:28
Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation: 27/07/2020, Revision: 2, Status: Authorised